Your clinician can guide you on managing this interaction
Its important to know the safe administration guidelines
Inflammation can lead to decreased T4 to T3 conversion, increased insulin resistance, and higher estrogen levels, all of which contribute to weight gain
At maximum doses, retatrutide has higher rates of nausea (43% vs 31%), vomiting (21% vs 12%), diarrhea (33% vs 23%), and constipation (25% vs 11%) compared to tirzepatide
doi: 10.1016/j.jaad.2014.03.031 72 LopezFRodrigoJPCardesaATriantafyllouADevaneyKOMendenhallWMet al
When managing various health factors throughout the GLP-1 journey, tools like MeAgain's GLP-1 app help you keep track of the full picture beyond what blood tests show